The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Code of Practice was first created in 1981 and is part of a decades-long commitment to promoting ethical practices in the pharmaceutical industry. The goal is to ensure that practices in the pharmaceutical industry are governed by ethical standards in line with societal expectations.
The Code has been revised six times since its inception. The current IFPMA Code of Practice came into effect on 1st January 2019, with the following changes compared to previous versions:
- Updates to several sections, including the introduction of a ban on gifts and promotional aids (for Rx based medicines).
- The development of an IFPMA Ethos, marking a shift from a rules-based to a values-based Code.
Abidance to the Code is mandatory for IFPMA members.
Last updated: 13.05.2020
This information is gathered from open-source data and in some cases has been provided by initiative facilitators. We cannot guarantee the accuracy or completeness of the information and do not take responsibility for decisions made on the basis of it. Please inform us of any errors by emailing us at the contact details on the main database page.